Literature DB >> 22005746

Performance trends and cardiac biomarkers in a 30-km cross-country race, 1993-2007.

Philip Aagaard1, Anders Sahlén, Frieder Braunschweig.   

Abstract

PURPOSE: Long-distance running events enjoy increasing popularity in all ages. Whereas the health benefits of regular moderate exercise are undisputed, the net health effects of single or repeated participation in endurance events of marathon type remain to be determined. We wanted to investigate performance trends over time and the relationship between race performance and cardiac biomarker levels among participants in a large annual 30-km cross-country race.
METHODS: We analyzed a database containing age, gender, run times, and previous race participation of 124,608 runners finishing the Lidingöloppet (30 km) between 1993 and 2007. In 249 male runners age ≥ 45 yr, we also performed a thorough cardiovascular examination, including measuring the cardiac biomarkers N-terminal pro-brain natriuretic peptide (NT-proBNP) and troponin.
RESULTS: Total participation increased 56% with the largest gains in younger female and older male runners. Mean run times rose from 164 ± 27 min in 1993 to 184 ± 33 min in 2007 (P < 0.001) in men and from 179 ± 26 to 203 ± 32 in women (P < 0.001) after a strong linear relationship (men, r = 0.98; women, r = 0.93). Increased run times were seen in the mean, top, and bottom quartiles as well as in the top and bottom 5% of all age and gender groups. In the substudy among 249 older male runners, not only higher body mass index, older age, and fewer previous race participations but also higher baseline NT-proBNP was independently associated with increased run time.
CONCLUSIONS: Whereas participation in the Lidingöloppet increased, fitness deteriorated over time in both genders and in all ages. In a subset of older male athletes, longer run times were associated with higher levels of NT-proBNP. The present findings may support the usefulness of preparticipation evaluation to ensure appropriate fitness and cardiovascular health in long-distance race participants.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22005746     DOI: 10.1249/MSS.0b013e31823cd051

Source DB:  PubMed          Journal:  Med Sci Sports Exerc        ISSN: 0195-9131            Impact factor:   5.411


  5 in total

1.  Altered ventriculo-arterial coupling during exercise in athletes releasing biomarkers after endurance running.

Authors:  Anders Sahlén; Kambiz Shahgaldi; Philip Aagaard; Aristomenis Manouras; Reidar Winter; Frieder Braunschweig
Journal:  Eur J Appl Physiol       Date:  2012-04-04       Impact factor: 3.078

2.  Performance trends in large 10-km road running races in the United States.

Authors:  Dan M Cushman; Matthew Markert; Monica Rho
Journal:  J Strength Cond Res       Date:  2014-04       Impact factor: 3.775

3.  Performance and cardiac evaluation before and after a 3-week training camp for 400-meter sprinters - An observational, non-randomized study.

Authors:  Michael Skalenius; C Mikael Mattsson; Pia Dahlberg; Lennart Bergfeldt; Annica Ravn-Fischer
Journal:  PLoS One       Date:  2019-05-31       Impact factor: 3.240

4.  Endurance exercise and the risk of cardiovascular pathology in men: a comparison between lifelong and late-onset endurance training and a non-athletic lifestyle - rationale and design of the Master@Heart study, a prospective cohort trial.

Authors:  Ruben De Bosscher; Christophe Dausin; Piet Claus; Jan Bogaert; Steven Dymarkowski; Kaatje Goetschalckx; Olivier Ghekiere; Ann Belmans; Caroline M Van De Heyning; Paul Van Herck; Bernard Paelinck; Haroun El Addouli; André La Gerche; Lieven Herbots; Hein Heidbuchel; Rik Willems; Guido Claessen
Journal:  BMJ Open Sport Exerc Med       Date:  2021-04-16

5.  Decline in cardiorespiratory fitness in the Swedish working force between 1995 and 2017.

Authors:  Elin Ekblom-Bak; Örjan Ekblom; Gunnar Andersson; Peter Wallin; Jonas Söderling; Erik Hemmingsson; Björn Ekblom
Journal:  Scand J Med Sci Sports       Date:  2018-11-15       Impact factor: 4.221

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.